Literature DB >> 5058233

Molecular analysis of the membrane attack mechanism of complement.

W P Kolb, J A Haxby, C M Arroyave, H J Müller-Eberhard.   

Abstract

The molecular arrangement of the membrane attack mechanism of complement was explored. The molar ratios of the components within the C5-9 assembly on the target cell surface were determined using human complement proteins in highly purified and radiolabeled form. With the aid of monospecific complement antisera it was possible to probe the spatial relationships between the components of the assembly. C5 and C6, in the presence of C7, were bound to EAC1-3 in equimolar quantities irrespective of the amounts and the relative proportions of C5, C6, and C7 offered. The amount of C8 bound to EAC1-7 increased with input and at saturation of all C8 binding sites the molar ratio of bound C8/bound C5 approached 1.0. Uptake of C9 by EAC1-8 increased with input and at saturation of all C9 binding sites the molar ratio of bound C9/bound C8 became 6.0. However, calculations suggest that the binding of three C9 molecules to one C8 molecule is sufficient to achieve a full hemolytic effect. Evidence was obtained indicating that binding and hemolytic function of C9 depends upon cooperative interaction of multiple C9 molecules. Binding of C8 to EAC1-7 and the generation of hemolytic C8 sites were inhibited by antibody to either C5, C6, or C7. Uptake of C9 by EAC1-8 and the generation of hemolytic C9 sites were strongly inhibited by anti-C8 and to a lesser degree by anti-C5. Binding of C9 (but not hemolysis) was also reduced by antibody to C6 or C7. The data are consistent with the concept that the fully assembled membrane attack mechanism of complement consists of a decamolecular complex: a trimolecular arrangement composed of C5, C6, and C7 forms the binding site for one C8 molecule which in turn furnishes binding sites for six C9 molecules, saturation of three sites apparently being sufficient for expression of full cytolytic activity of the complex. This work made it possible to design a simple molecular model.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5058233      PMCID: PMC2139138          DOI: 10.1084/jem.135.3.549

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

Review 1.  Quaternary structure of proteins.

Authors:  I M Klotz; N R Langerman; D W Darnall
Journal:  Annu Rev Biochem       Date:  1970       Impact factor: 23.643

2.  Enhancement of hemolytic complement activity by treatment of human serum with iodine.

Authors:  M J Polley
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

3.  Fate of phospholipids in liposomal model membranes damaged by antibody and complement.

Authors:  K Inoue; S C Kinsky
Journal:  Biochemistry       Date:  1970-11-24       Impact factor: 3.162

4.  The fifth component of the guinea pig complement system. II. Mechanism of SAC1,4,2,3,5b formation and C5 consumption by EAC1,4,2,3.

Authors:  H S Shin; R J Pickering; M M Mayer
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

5.  The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.

Authors:  N R Cooper; M J Polley; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1970-04

6.  A comparison of methods for the molecular quantitation of the fourth component of human complement.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1968-03

7.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

8.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

9.  Production of ultrastructural membrane lesions by the fifth component of complement.

Authors:  M J Polley; H J Müller-Eberhard; J D Feldman
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

10.  Lysis of erythrocytes by complement in the absence of antibody.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  49 in total

1.  Binding of the complement intermediate C56 to zymosan in acute phase human sera.

Authors:  P J Baker; L G Rubin; T F Lint; B C McLeod; H Gewurz
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Release of 14C label and complement killing of Escherichia coli.

Authors:  B M Wilson; A A Glynn
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

3.  Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.

Authors:  E A Jaffe; R L Nachman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

4.  Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex.

Authors:  Alexander E Aleshin; Richard G DiScipio; Boguslaw Stec; Robert C Liddington
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

5.  Electron spin resonance studies on interaction of complement proteins with erythrocyte membranes.

Authors:  C E Dahl; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

7.  Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.

Authors:  D W Michaels; A S Abramovitz; C H Hammer; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

8.  Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.

Authors:  B McLeod; P Baker; H Gewurz
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

9.  Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.

Authors:  E R Podack; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; P A Thiem; J P Leddy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.